Patients with oligodendroglioma, astrocytoma, and GBM exhibited elevated median frequencies of CD56+/CD94+ NK cells compared to the healthy controls (6.9%, 7.4%, and 5.6%, respectively, versus 4.5% in the healthy control cohort, Figure 5D). This evidence concerns the gene NCAM1 and glioblastoma.